FindTrial
Sign In

End of intensive phase sputum status in pulmonary tuberculosis patients with type 2 diabetes mellitus , a prospective cohort study.

End of intensive phase sputum status in pulmonary tuberculosis patients with type 2 diabetes mellitus . - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080604
Enrollment
150
Registered
2025-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Control Intervention1: N/A: N/A

Sponsors

DEEKSHA S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pulmonary tuberculosis patients with diabetes mellitus

Exclusion criteria

Exclusion criteria: Pulmonary tuberculosis patients without diabetes Pulmonary tuberculosis patients with immunocompromised condition

Design outcomes

Primary

MeasureTime frame
the sputum smear status of microbiologically confirmed pulmonary tuberculosis patients with and without type two diabetes mellitus at the end of intensive phase of anti tuberculosis treatment is comparedTimepoint: the sputum smear status of microbiologically confirmed pulmonary tuberculosis patients with and without type two diabetes mellitus at the end of intensive phase that is after 8 weeks of anti tuberculosis treatment is compared—

Secondary

MeasureTime frame
the risk factors associated with delayed sputum conversion are evaluatedTimepoint: risk factors are evaluated at the end of 8 weeks after starting Antitubercular treatment—

Countries

India

Contacts

Public ContactDeekshaS

KMC , MANIPAL

manu.mohan@manipal.edu9964896253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026